Related Experiment Video
Updated: Apr 26, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Hypoxia represses microRNA biogenesis proteins in breast cancer cells
Veronika Bandara, Michael Z Michael, Jonathan M Gleadle1
1Renal Department, Flinders Medical Centre, Flinders University School of Medicine, Bedford Park, Adelaide, South Australia 5042, Australia. jonathan.gleadle@health.sa.gov.au.
Background:
Cancers are commonly characterised by hypoxia and also by global reductions in the levels of mature microRNAs. We have examined the hypothesis that hypoxia might mediate this reduction through repressive effects on microRNA biogenesis proteins.
Methods:
Breast cancer cell lines were exposed to hypoxia and manipulations of hypoxia inducible factor (HIF) and HIF hydroxylase activity. The effects of hypoxia on the mRNA and protein levels of enzymes involved in microRNA biogenesis (Dicer, Drosha, TARPB2, DCGR8, XPO5) was determined by RT PCR and immunoblotting. The effect of hypoxia on microRNAs was determined with microarray studies, RT PCR and reporter assays.
Results:
In breast cancer lines there was significant reduction of Dicer mRNA and protein levels in cells exposed to hypoxia. This effect was independent of HIF but dependent on the HIF hydroxylase PHD2 and was partly mediated by feedback effects via microRNAs. Furthermore, several other proteins with critical roles in microRNA biogenesis (Drosha, TARBP2 and DCGR8) also showed significant and co-ordinated repression under hypoxic conditions. Despite these substantial alterations no, or modest, changes were observed in mature microRNA production.
Conclusion:
These observations provide further and important interfaces between oxygen availability and gene expression and a potential mechanistic explanation for the reduced levels of microRNAs observed in some cancers. They provide further support for the existence of feedback mechanisms in the regulation of the microRNA biogenesis pathway and the relative stability of microRNAs.
Insights
Hypoxia in breast cancer reduces microRNA biogenesis proteins like Dicer, Drosha, and TARBP2. This suggests a mechanism for lower microRNA levels in cancers, highlighting oxygen's role in gene expression.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Cancers often exhibit hypoxia and reduced mature microRNA levels.
- Hypoxia may decrease microRNAs by repressing biogenesis proteins.
Purpose of the Study:
- Investigate if hypoxia reduces microRNA levels by affecting microRNA biogenesis proteins.
- Explore the link between oxygen availability and gene expression in cancer.
Main Methods:
- Exposed breast cancer cell lines to hypoxia.
- Assessed mRNA and protein levels of microRNA biogenesis enzymes (Dicer, Drosha, TARPB2, DCGR8, XPO5) using RT-PCR and immunoblotting.
- Analyzed microRNA levels via microarrays, RT-PCR, and reporter assays.
Main Results:
- Hypoxia significantly reduced Dicer mRNA and protein in breast cancer cells, independent of HIF but dependent on PHD2.
- Other key microRNA biogenesis proteins (Drosha, TARPB2, DCGR8) were also repressed under hypoxia.
- Despite these changes, mature microRNA production showed minimal alteration.
Conclusions:
- Oxygen availability influences gene expression and may explain reduced microRNAs in some cancers.
- Findings support feedback mechanisms in microRNA biogenesis regulation.
- Demonstrates the relative stability of mature microRNAs even with biogenesis pathway alterations.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

